MDIC Celebrates Dr. Michelle Tarver as Newly Appointed Director of FDA CDRH
Celebrating Dr. Michelle Tarver's Appointment as Director of FDA’s Center for Devices and Radiological Health
The Medical Device Innovation Consortium (MDIC), the first public-private partnership created with the sole objective of advancing medical device regulatory science, congratulates Dr. Michelle Tarver on her appointment as permanent director of the FDA’s Center for Devices and Radiological Health (CDRH).
Dr. Tarver has a long history of contributing to patient-centric initiatives convened by MDIC, including programs focused on health equity and incorporating quality across the total product lifecycle. Our dedicated stakeholders are pleased that her appointment signals continued opportunities to foster deeper collaboration across the healthcare ecosystem, including agency partners, to advance our collective mission. Board-certified in ophthalmology with a doctorate in epidemiology, Dr. Tarver is a seasoned leader at the agency, having focused her career on advancements that support better outcomes for all patients.
“Dr. Tarver has worked with MDIC for many years, and I could not be more pleased with this well-deserved appointment,” said Andrew C. Fish, President and CEO of MDIC. “Dr. Tarver is a visionary leader who believes in the power of collaboration to improve patient care. Her support for incorporating patient needs and perspectives, improving quality manufacturing, and advancing regulatory evidence development will be foundational to our continued work with Dr. Tarver in her new role as CDRH Director.”
MDIC advances regulatory science for medical devices to ensure that the best healthcare technology can reach those in need as quickly as possible. Our work focuses on advancing quality design and manufacturing, evidence generation, digital technology, and patient engagement, and our impact highlights the importance of public-private partnerships in improving regulatory science.
As Dr. Tarver steps into her new role, MDIC looks forward to continuing its work with our agency partners and all key stakeholders to accelerate the path to patients for life-supporting technology. Dr. Tarver’s leadership will contribute to fostering innovation, enhancing patient safety, and improving health outcomes for all. The MDIC community looks forward to everything that will come from CDRH under her extraordinary leadership.
Contacts
Erica Freeze, Associate Director of Communications, MDIC
efreeze@mdic.org